The COVID-19 pandemic threatens to reverse recent progress in reducing the global burden of Tuberculosis

Home / Healthcare and public health research / The COVID-19 pandemic threatens to reverse recent progress in reducing the global burden of Tuberculosis

The COVID-19 pandemic threatens to reverse recent progress in reducing the global burden of Tuberculosis

November 21, 2020 Dario Scaramuzzi 0 Comments 5 tags

The COVID-19 pandemic threatens to reverse recent progress in reducing the global burden of tuberculosis. The global number of deaths for tuberculosis could increase by around 200.000–400.000 in 2020 alone, as result of essential tuberculosis services disruptions due to the reallocation of human, financial and other resources from tuberculosis to the COVID-19 response, as reported by WHO: https://bit.ly/35KyzD

Explore More

Liberia

With comments as “the project is likely to have a significant impact”, and “this project will make a substantial contribution to the expected impact”, the reviewers of the European Union

SEARCH (SouthErn Africa Regulatory for Clinical researcH) is a consortium of Southern African countries (Mozambique, Swaziland, Lesotho and Botswana) and European Union, aimed to increase the capacity of the National

Ebola vaccine candidates are currently being evaluated in phase I–III clinical trials conducted in Africa, the EU and the US. Although preclinical development of candidate vaccines utilise different platforms, including

The COVID-19 pandemic threatens to reverse recent progress in reducing the global burden of Tuberculosis

Leave a Reply Cancel reply

Explore More

Liberia

SEARCH

Ebola vaccines at a la glance